Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INOVA: Bevacizumab Neoadjuvant Strategies in Rectal Cancer
NCT00865189Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2007
- Primary completion
- Mar 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by Roche. Started Oct 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00865189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865189.